Firms
Theme

AMN

AMN Healthcare Services · NYSE

News

2 latest

Zacks Investment Research

Strength Seen in AMN Healthcare (AMN): Can Its 8.9% Jump Turn into More Strength?

AMN Healthcare shares surged 8.9% to $46.82, driven by investor optimism about recovery in healthcare staffing demand and stronger-than-expected Q2 2026 results. However, the stock carries a Zacks Rank #3 (Hold) rating as earnings estimate revisions have remained flat over the past 30 days, suggesting the recent momentum may not sustain without positive estimate changes.

Zacks Investment Research

Here's Why You Should Retain AMN Stock in Your Portfolio for Now

AMN Healthcare is positioned for growth driven by rising healthcare staffing demand, technology investments, and higher-margin services, with Nurse and Allied revenues up 11% and Passport users growing 33%. However, persistent pricing competition, weakness in physician and technology segments, and earnings normalization pose significant headwinds to sustained performance.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $AMN · 0 threads

Sign in to post on $AMN

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev